Alkem Laboratories has received an Establishment Inspection Report from the US Food and Drug Administration for its manufacturing facility at Amaliya, Daman. The US drug authority had conducted the inspection between March 19 and 27 and issued 13 observations. Alkem Labs had submitted a detailed corrective and preventive action plan to the regulator within the stipulated timelines. The inspection has now been closed by the US FDA. Shares of Alkem Lab are likely to remain in focus.